Mouse Monoclonal Importin 13 antibody. Proliferation marker. Suitable for IHC-P, ICC/IF, IHC-Fr and reacts with Mouse, Rat, Human samples. Immunogen corresponding to Cell preparation containing IPO 38 protein.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
| IHC-P | ICC/IF | IHC-Fr | |
|---|---|---|---|
| Human | Expected | Expected | Expected |
| Mouse | Expected | Expected | Expected |
| Rat | Expected | Expected | Expected |
| Species | Dilution info | Notes |
|---|---|---|
Species Mouse, Rat, Human | Dilution info Use at an assay dependent concentration. | Notes - |
| Species | Dilution info | Notes |
|---|---|---|
Species Mouse, Rat, Human | Dilution info Use at an assay dependent concentration. | Notes - |
| Species | Dilution info | Notes |
|---|---|---|
Species Mouse, Rat, Human | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
Mouse Monoclonal Importin 13 antibody. Proliferation marker. Suitable for IHC-P, ICC/IF, IHC-Fr and reacts with Mouse, Rat, Human samples. Immunogen corresponding to Cell preparation containing IPO 38 protein.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
Bioreactor Concentrate
ab190704 recognizes a protein of 14-16kDa, which is a novel nuclear antigen of proliferating cells. IPO 38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO 38 can be a useful marker of cell proliferation during monitoring of tumor progression.
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
IPO 38 also known as Interphotoreceptor Retinoid Binding Protein (IRBP) is a protein involved in the transport of retinoids and fatty acids. It has a molecular weight of approximately 140 kDa. This protein is expressed in the retina and pineal gland where it plays a role in visual processes. The IPO 38 serves as a carrier facilitating the movement of essential molecules between the photoreceptor cells and the retinal pigment epithelium aiding in visual function.
IPO 38 functions as a significant player in the visual cycle. It interacts with both retinoids and lipids indicating its involvement in the visual signal transduction process. This protein associates with complexes that modulate the transfer of retinoids supporting the regeneration of 11-cis-retinal which is vital for the formation of the visual pigments in photoreceptor cells. It stabilizes retinoids within the interphotoreceptor matrix ensuring efficient transport and protection from degradation.
The protein plays an important role in both the visual cycle and the retinoid metabolic processes. In the visual cycle IPO 38 interacts with other proteins like rhodopsin to ensure light perception and signal transduction within the photoreceptor cells. By participating in the retinoid signaling pathway it helps facilitate the conversion of all-trans-retinol into 11-cis-retinal an active form necessary for vision. Its association with these pathways highlights its role in maintaining proper vision and retinal health.
Disruptions in IPO 38 function link to certain retinal dystrophies including retinitis pigmentosa and age-related macular degeneration (AMD). In these conditions dysfunction in the transport of retinoids and lipids leads to photoreceptor cell degeneration. The protein's interaction with rhodopsin plays a role in these disorders as any impairment in the pathway may contribute to the pathological state. Research into IPO 38 provides insight into therapeutic targets for combating vision loss associated with these diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com